But at OSE Immunotherapeutics, which aims to prevent cancers via vaccines, the news is encouraging. The French company recently announced that it has launched a global Phase 3 trial for its cancer ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback